Natco Pharma gains on getting nod for Molnupiravir Capsules for Covid-19 treatment in India

natco pharma surges on getting eir from usfda for api facility in hyderabad

Natco Pharma is currently trading at Rs. 899.10, up by 8.65 points or 0.97% from its previous closing of Rs. 890.45 on the BSE. The scrip opened at Rs. 900.00 and has touched a high and low of Rs. 910.00 and Rs. 895.30 respectively. So far 12163 shares were traded on the counter. The BSE … Read more

BREAKING NEWS:
Bajaj’s electric bike: No mileage worries ahead! Affordable Fun: Best 5G Smartphones Under ₹15,000! Airtel’s Cheapest Calling Plan Lasts a Year